![Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS - Analytical Methods (RSC Publishing) DOI:10.1039/D2AY01254E Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS - Analytical Methods (RSC Publishing) DOI:10.1039/D2AY01254E](https://pubs.rsc.org/image/article/2022/AY/d2ay01254e/d2ay01254e-f5_hi-res.gif)
Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS - Analytical Methods (RSC Publishing) DOI:10.1039/D2AY01254E
![Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome | Journal of Pharmacology and Experimental Therapeutics Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/373/2/193/F5.large.jpg)
Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome | Journal of Pharmacology and Experimental Therapeutics
![Teduglutide-d8 TFA salt x hydrate (Leu-methyl-d3+Phe-d5) | 1: PN: US20130072430 SEQID: 4 Claimed Protein-d8; ALX 0600-d8; Gattex-d8; Glucagon-like Peptide II [2-Glycine] (Human)-d8; Revestive-d8; | C₁₆₄H₂₄₄D₈N₄₄O₅₅S • C₂HF₃O₂ • x( H₂O) | TRC Teduglutide-d8 TFA salt x hydrate (Leu-methyl-d3+Phe-d5) | 1: PN: US20130072430 SEQID: 4 Claimed Protein-d8; ALX 0600-d8; Gattex-d8; Glucagon-like Peptide II [2-Glycine] (Human)-d8; Revestive-d8; | C₁₆₄H₂₄₄D₈N₄₄O₅₅S • C₂HF₃O₂ • x( H₂O) | TRC](https://www.trc-canada.com/prod-img/T013798.png)
Teduglutide-d8 TFA salt x hydrate (Leu-methyl-d3+Phe-d5) | 1: PN: US20130072430 SEQID: 4 Claimed Protein-d8; ALX 0600-d8; Gattex-d8; Glucagon-like Peptide II [2-Glycine] (Human)-d8; Revestive-d8; | C₁₆₄H₂₄₄D₈N₄₄O₅₅S • C₂HF₃O₂ • x( H₂O) | TRC
![Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing - ScienceDirect Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0939641123000012-gr1.jpg)
Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing - ScienceDirect
![Buy Hot selling Teduglutide 197922-42-2 with good price Research and Industrial Grade from Hangzhou Go Top Peptide Biotech Co.,Ltd. - ECHEMI Buy Hot selling Teduglutide 197922-42-2 with good price Research and Industrial Grade from Hangzhou Go Top Peptide Biotech Co.,Ltd. - ECHEMI](https://acf-file.echemi.com/fileManage/upload/goodpicture/20210622/b20210622164053832.png)
Buy Hot selling Teduglutide 197922-42-2 with good price Research and Industrial Grade from Hangzhou Go Top Peptide Biotech Co.,Ltd. - ECHEMI
![Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome - ScienceDirect Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0022347616310952-ympd8737-fig-0001.jpg)
Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome - ScienceDirect
![Teduglutide influences structural hypertrophy. a Representative H.E.... | Download Scientific Diagram Teduglutide influences structural hypertrophy. a Representative H.E.... | Download Scientific Diagram](https://www.researchgate.net/publication/339358892/figure/fig3/AS:860286131122179@1582119605989/Teduglutide-influences-structural-hypertrophy-a-Representative-HE-sections-through.png)
Teduglutide influences structural hypertrophy. a Representative H.E.... | Download Scientific Diagram
![The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome | ACS Pharmacology & Translational Science The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome | ACS Pharmacology & Translational Science](https://pubs.acs.org/cms/10.1021/acsptsci.9b00016/asset/images/medium/pt-2019-00016v_0004.gif)
The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome | ACS Pharmacology & Translational Science
![Teduglutide-d8 (Phe-d8) | 1: PN: US20130072430 SEQID: 4 Claimed Protein-d8; ALX 0600-d8; Gattex-d8; Glucagon-like Peptide II [2-Glycine] (Human)-d8; Revestive-d8; | C₁₆₄H₂₄₄D₈N₄₄O₅₅S | TRC Teduglutide-d8 (Phe-d8) | 1: PN: US20130072430 SEQID: 4 Claimed Protein-d8; ALX 0600-d8; Gattex-d8; Glucagon-like Peptide II [2-Glycine] (Human)-d8; Revestive-d8; | C₁₆₄H₂₄₄D₈N₄₄O₅₅S | TRC](https://www.trc-canada.com/prod-img/T013797.png)
Teduglutide-d8 (Phe-d8) | 1: PN: US20130072430 SEQID: 4 Claimed Protein-d8; ALX 0600-d8; Gattex-d8; Glucagon-like Peptide II [2-Glycine] (Human)-d8; Revestive-d8; | C₁₆₄H₂₄₄D₈N₄₄O₅₅S | TRC
![The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome | ACS Pharmacology & Translational Science The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome | ACS Pharmacology & Translational Science](https://pubs.acs.org/cms/10.1021/acsptsci.9b00016/asset/images/large/pt-2019-00016v_0003.jpeg)
The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome | ACS Pharmacology & Translational Science
![Chemical synthesis of teduglutide using CSY a Sequence of teduglutide 9... | Download Scientific Diagram Chemical synthesis of teduglutide using CSY a Sequence of teduglutide 9... | Download Scientific Diagram](https://www.researchgate.net/publication/339383466/figure/fig4/AS:958993174364160@1605653198098/Chemical-synthesis-of-teduglutide-using-CSY-a-Sequence-of-teduglutide-9-with-motifs-prone.png)